NERADIL, Jakub, Renata VESELSKÁ a Augustin SVOBODA. The role of actin in the apoptotic cell death of P19 embryonal carcinoma cells. International Journal of Oncology. 2005, roč. 27, č. 4, s. 1013-1022. ISSN 1019-6439.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The role of actin in the apoptotic cell death of P19 embryonal carcinoma cells.
Název česky Úloha aktinu v apoptóze embryonálních karcinomových buněk linie P19.
Autoři NERADIL, Jakub (203 Česká republika, garant), Renata VESELSKÁ (203 Česká republika) a Augustin SVOBODA (203 Česká republika).
Vydání International Journal of Oncology, 2005, 1019-6439.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10600 1.6 Biological sciences
Stát vydavatele Česká republika
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 2.681
Kód RIV RIV/00216224:14110/05:00012573
Organizační jednotka Lékařská fakulta
UT WoS 000232088700018
Klíčová slova anglicky apoptosis; actin cytoskeleton; fractin; caspase-3; all-trans retinoic acid; cell differentiation
Štítky actin cytoskeleton, all-trans retinoic acid, apoptosis, caspase-3, cell differentiation, fractin
Změnil Změnil: doc. RNDr. Jakub Neradil, Ph.D., učo 10009. Změněno: 23. 8. 2005 15:32.
Anotace
The P19 mouse embryonal carcinoma cell line was used as a model for a study of apoptosis accompanying differentiation induced by all-trans retinoic acid (ATRA). Apoptosis was detected both on the basis of morphological features (nuclear fragmentation, blebbing of plasma membrane, and formation of apoptotic bodies), and by using DNA electrophoresis and flow-cytometric measurement of DNA content. Actin cytoskeleton was studied both on morphological and submicroscopic levels. ATRA-treated cells manifested apoptosis-specific changes in the distribution of actin foremost in association with their entry into executive phase of apoptosis, when F-actin cables participated in cell disintegration into apoptotic bodies. Using immunogold labeling, actin was also identified in centers of fragmenting apoptotic nuclei, in the disintegration of which it is likely involved as well. At the same time, a cleavage of actin by active caspase-3 was proved, resulting in the emergence of 32kDa fragment termed fractin. Measurement of F-actin and fractin content using flow cytometry showed an unequivocal decrease of F-actin and synchronous increase of fractin in the apoptotic population as compared to non-treated cells. Therefore, our results proved both actin proteolysis and active involvement of specific actin structures in the final cell disintegration during apoptosis in the P19 cells.
Anotace česky
The P19 mouse embryonal carcinoma cell line was used as a model for a study of apoptosis accompanying differentiation induced by all-trans retinoic acid (ATRA). Apoptosis was detected both on the basis of morphological features (nuclear fragmentation, blebbing of plasma membrane, and formation of apoptotic bodies), and by using DNA electrophoresis and flow-cytometric measurement of DNA content. Actin cytoskeleton was studied both on morphological and submicroscopic levels. ATRA-treated cells manifested apoptosis-specific changes in the distribution of actin foremost in association with their entry into executive phase of apoptosis, when F-actin cables participated in cell disintegration into apoptotic bodies. Using immunogold labeling, actin was also identified in centers of fragmenting apoptotic nuclei, in the disintegration of which it is likely involved as well. At the same time, a cleavage of actin by active caspase-3 was proved, resulting in the emergence of 32kDa fragment termed fractin. Measurement of F-actin and fractin content using flow cytometry showed an unequivocal decrease of F-actin and synchronous increase of fractin in the apoptotic population as compared to non-treated cells. Therefore, our results proved both actin proteolysis and active involvement of specific actin structures in the final cell disintegration during apoptosis in the P19 cells.
Návaznosti
GA304/00/0403, projekt VaVNázev: Změny cytoskeletu buněk nádorových linií v průběhu indukované apoptózy v závislosti na stádiu diferenciace.
Investor: Grantová agentura ČR, Změny cytoskeletu buněk nádorových linií v průběhu indukované apoptózy v závislosti na stádiu diferenciace
VytisknoutZobrazeno: 26. 8. 2024 06:25